NEW YORK, NY–(Marketwired – Mar 24, 2016) – Dr. Patricia Broderick serves in the same proportion that a Medical Professor in Physiology, Pharmacology and Neuroscience and is Course Director in Pharmacology as far as concerns the Physician’s Assistant Program at the City University of New York School of Medicine; Sophie Davis School of Biomedical Education at City College. Dr. Broderick is in addition part of the Doctoral Faculty in Biology (Neuroscience) at the City University of New York Graduate School. Additionally, she serves since an Adjunct Professor in Neurology at the NYU Langone Medical Center and Comprehensive Epilepsy Center. In 2000, Dr. Patricia Broderick established the Broderick Brain Foundation, what one. promotes neuroscience education and research as long as encouraging and supporting those exploring and expanding of the healing art science boundaries. She is also some author, lecturer, researcher and the author of the BRODERICK PROBE®.
With one impressive educational background, Dr. Patricia Broderick earned a Bachelor of Science Degree from St. Thomas Aquinas College, graduating Magna Cum Laude. Continuing through her education, she earned a Master of Science Degree in Biology from Fordham University and a Ph.D. in Pharmacology from St. John’s University. She has also completed Postdoctoral and Research Associate be in action at the Albert Einstein College of Medicine and the Cornell University Medical School.
It is uncompliant to ascertain where to begin then describing such a uniquely accomplished individual of the like kind as Dr. Patricia Broderick. She began her career as a Senior Scientist at USV Pharmaceutical (1979-1982), face to face with becoming Scientific Consultant and Research Investigator at Pharmacia Upjohn Pharmaceuticals Company (1982-1988). She therefore took the position that she has held with a view to the last 29 plus years in the same manner with Medical Professor in Physiology, Pharmacology and Neuroscience at the Sophie Davis School of Biomedical Education, CCNY, City University of New York School of Medicine. She is also an accomplished author, recently finishing her volume, Neuroimaging, Sensing Biochemistry in the Brain, which is being published by Pan Stanford Publishing Pte Ltd., Singapore.
After divers years of research and study, she has invented the BRODERICK PROBE® biosensors and related biotechnologies. The BRODERICK PROBE®, named beneficial to her father, is a diagnostic biomedical scheme that sends neurotransmitter images in veritable time from the brain during live mental action and is able to video vestige the brain in order to individually and uniquely design a constant’s treatment. This invention has get to be an essential tool in the study of method of treating options for neurological degenerative diseases and medicine addictions. The probe uses a concatenation of biosensors for this unique emblem of Neuromolecular Imaging Technique (NMI).
True to her earnest personality, Dr. Patricia Broderick has in like manner co-founded, with Canadian Stephen Jones, Ph.D., EMBA, a of the present day nanotechnology company called Eazysense Nanotechnologies Inc. This New York incorporated society was established in order to do this unique brain nanobiosensor available and affordable during the term of healthcare professionals and students on a global scale.
In addition to her research and settlement endeavors, Dr. Patricia Broderick shares her unique and significant education, expertise and skills in the educational arena (as previously stated) as well being of the kind which being one of the most sought-after lecturers and symposium leaders throughout the native land.
Further tapping into the pulse of the range, Dr. Patricia Broderick is a portion of: The Society for Neuroscience; the American Society by reason of Pharmacology and Experimental Therapies; the Association against Women in Science; the Electrochemical Society; and the American Epilepsy Society. Additionally, she is a Member of the Board, Sensors; Member of the Board, Biosensors (Basel, Switzerland and Beijing, China), The Journal of Neural Transmission; Member of the Board and Field Editor (Heidelberg, Germany), The Journal of Caffeine Research; maker Member of the Board, Editor-in-Chief (New York, USA), The Journal of Biochips and Tissue Chips; Member of the Board and Editor-in-Chief (Henderson, Nevada, USA), Advisory Board, de Gruyters Open Access Chemical Sensors; Member of the Editorial Board, and E Chronicon Neurology and E Chronicon Pharmacology and Toxicology.
Throughout her brilliant career, Dr. Patricia Broderick has received numerous honors and awards: St. Thomas Aquinas College, New York, Magna Cum Laude, Teacher Leadership Award; New York University, Research Fellowship; Nathan Kline Psychiatric Institute, Teaching Fellowship; St. John’s University, Rho Chi National Pharmaceutical Honor Society; St. John’s University, Milton Rosenbaum Award from the Albert Einstein College of Medicine – Montefiore Medical Center; the Albert Einstein College of Medicine of Yeshiva University, Advanced Biomedical Studies Certificate; City College of New York, Faculty Senate Committee up~ the body Research and Publication Award; Association of Women in Science, Outstanding Woman Scientist Award; and Sigma Xi Research Honor Society. Additionally, Dr. Broderick has been one invited speaker at the International Congress and Exhibition up~ Biosensors and Bioelectronics: Analyzing Novel Approaches to Biosensors and Bioelectronics, in Las Vegas, Nevada.
With one impressive educational background, countless hours of exploration, the years spent educating and mentoring others, person obtains a mere glimpse of Dr. Patricia Broderick’s devotion to the well-being of her patients, her students and her intrusting to the study and exploration of the brain, its functionalities, and its limitless possibilities.
Image Available: http://www2.marketwire.com/mw/frame_mw?attachid=2983450
Image Available: http://www2.marketwire.com/mw/frame_mw?attachid=2983452
Image Available: http://www2.marketwire.com/mw/frame_mw?attachid=2983454
Image Available: http://www2.marketwire.com/mw/frame_mw?attachid=2983456
Adults in cells of patients that designate products, on the normal infarct, take well-tolerated.